Cargando…

Protection by alpha 1-acid glycoprotein against tumor necrosis factor- induced lethality

We here report that alpha 1-acid glycoprotein, a typical acute phase protein, protects mice from lethal shock induced by tumor necrosis factor (TNF) or endotoxin. The protection is observed both in normal and in galactosamine-sensitized mice. Optimal desensitization requires at least 3 mg alpha 1-ac...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1994
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2191695/
https://www.ncbi.nlm.nih.gov/pubmed/7931089
_version_ 1782147065218859008
collection PubMed
description We here report that alpha 1-acid glycoprotein, a typical acute phase protein, protects mice from lethal shock induced by tumor necrosis factor (TNF) or endotoxin. The protection is observed both in normal and in galactosamine-sensitized mice. Optimal desensitization requires at least 3 mg alpha 1-acid glycoprotein administered 2 h before the lethal challenge. Under these conditions, complete inhibition of all TNF-induced metabolic changes was observed: fall in body temperature, release of liver transaminases, enhanced clotting time, and mortality. The known platelet aggregation-inhibitory activity of alpha 1-acid glycoprotein provides a possible explanation for this protective capacity.
format Text
id pubmed-2191695
institution National Center for Biotechnology Information
language English
publishDate 1994
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21916952008-04-16 Protection by alpha 1-acid glycoprotein against tumor necrosis factor- induced lethality J Exp Med Articles We here report that alpha 1-acid glycoprotein, a typical acute phase protein, protects mice from lethal shock induced by tumor necrosis factor (TNF) or endotoxin. The protection is observed both in normal and in galactosamine-sensitized mice. Optimal desensitization requires at least 3 mg alpha 1-acid glycoprotein administered 2 h before the lethal challenge. Under these conditions, complete inhibition of all TNF-induced metabolic changes was observed: fall in body temperature, release of liver transaminases, enhanced clotting time, and mortality. The known platelet aggregation-inhibitory activity of alpha 1-acid glycoprotein provides a possible explanation for this protective capacity. The Rockefeller University Press 1994-10-01 /pmc/articles/PMC2191695/ /pubmed/7931089 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Articles
Protection by alpha 1-acid glycoprotein against tumor necrosis factor- induced lethality
title Protection by alpha 1-acid glycoprotein against tumor necrosis factor- induced lethality
title_full Protection by alpha 1-acid glycoprotein against tumor necrosis factor- induced lethality
title_fullStr Protection by alpha 1-acid glycoprotein against tumor necrosis factor- induced lethality
title_full_unstemmed Protection by alpha 1-acid glycoprotein against tumor necrosis factor- induced lethality
title_short Protection by alpha 1-acid glycoprotein against tumor necrosis factor- induced lethality
title_sort protection by alpha 1-acid glycoprotein against tumor necrosis factor- induced lethality
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2191695/
https://www.ncbi.nlm.nih.gov/pubmed/7931089